Does GHK-Cu work?
Mostly in cells and animals, not yet shown in people. A review of topical GHK concluded that, on cell-study evidence, it can be considered an anti-wrinkle ingredient, but a cell result is not a result in people.
Short answer
Mostly in cells and animals, not yet shown in people. A review of topical GHK concluded that, on cell-study evidence, it can be considered an anti-wrinkle ingredient, but a cell result is not a result in people.[1]
In rats after knee ligament reconstruction, GHK-Cu helped early but the benefit was gone by the later check, so even the animal effect was temporary.[2]
How it is thought to act
In mice with silicosis, GHK-Cu bound a protein called PRDX6 and reduced lung inflammation and fibrosis, one proposed mechanism.[3]
In rats, the peptide was quickly degraded in plasma to a smaller fragment (HK), which was also eliminated quickly.[4]
Common questions
How does copper peptide work?
In the mouse silicosis study the effects were partly related to the inhibition of oxidative stress in lung macrophages by GHK-Cu. This is animal and cell work; the mechanism in people has not been shown.[3]
More questions on GHK-Cu
More on GHK-Cu
Sources
- 1Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective.BioImpacts : BI · 2025PMID 39963574Accessed 2 Oct 2026
- 2Tripeptide-copper complex GHK-Cu (II) transiently improved healing outcome in a rat model of ACL reconstruction.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2015PMID 25731775Accessed 2 Oct 2026
- 3The glycyl-l-histidyl-l-lysine-Cu2+ tripeptide complex attenuates lung inflammation and fibrosis in silicosis by targeting peroxiredoxin 6.Redox biology · 2024PMID 38879894Accessed 2 Oct 2026
- 4Simultaneous determination of glycyl-L-histidyl-L-lysine and its metabolite, L-histidyl-L-lysine, in rat plasma by high-performance liquid chromatography with post-column derivatization.Journal of chromatography. B, Biomedical sciences and applications · 1997PMID 9187381Accessed 2 Oct 2026
Found an error? Report a correction.